Pneumocystis jiroveci Pneumonia in Patients with Non-Hodgkin's Lymphoma Receiving Chemotherapy Containing Rituximab

被引:17
作者
Chang, Hung [1 ,4 ]
Yeh, Huei-Chung [2 ]
Su, Yung-Cheng
Lee, Ming-Hsun [3 ,4 ]
机构
[1] Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Tao Yuan 333, Taiwan
[2] Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Tao Yuan 333, Taiwan
[3] Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Tao Yuan 333, Taiwan
[4] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan
关键词
febrile neutropenia; lymphoma; opportunistic infection; Pneumocystis jiroveci; rituximab;
D O I
10.1016/S1726-4901(08)70173-4
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Rituximab enhances treatment efficacy of B-lineage lymphoma by targeting CD20(+) B-cells. Such target therapies may compromise the immune system and render patients susceptible to opportunistic infections. We report 2 cases of lymphoma complicated with Pneumocystis jiroveci (previously known as P carinii) pneumonia (PCP) while being treated with rituximab-containing chemotherapy regimens. In both cases, PCP developed during the neutropenic period. With timely diagnosis and proper management, both were treated successfully. We searched the literature and found that such opportunistic infection occurred only infrequently in lymphoma patients, and it has not been reported in the large-scale clinical trials of rituximab. Such cases demonstrate the importance of taking PCP into diagnostic consideration in lymphoma patients receiving similar therapies. [J Chin Med Assoc 2008;71(11):579-582]
引用
收藏
页码:579 / 582
页数:4
相关论文
共 15 条
[1]
Barbounis V, 2005, ANTICANCER RES, V25, P651
[2]
Brusamolino E, 2006, HAEMATOLOGICA, V91, P496
[3]
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].
Coiffier, B ;
Lepage, E ;
Brière, J ;
Herbrecht, R ;
Tilly, H ;
Bouabdallah, R ;
Morel, P ;
Van den Neste, E ;
Salles, G ;
Gaulard, P ;
Reyes, F ;
Gisselbrecht, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242
[4]
1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever [J].
Hughes, WT ;
Armstrong, D ;
Bodey, GP ;
Brown, AE ;
Edwards, JE ;
Feld, R ;
Pizzo, P ;
Rolston, KVI ;
Shenep, JL ;
Young, LS .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) :551-573
[5]
Infectious Diseases Society of Taiwan, 2005, J Microbiol Immunol Infect, V38, P455
[6]
Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole [J].
Korraa, H ;
Saadeh, C .
SOUTHERN MEDICAL JOURNAL, 1996, 89 (03) :272-277
[7]
Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP [J].
Lin, Peng-Chan ;
Hsiao, Liang-Tsai ;
Poh, Say-Bee ;
Wang, Wei-Shu ;
Yen, Chueh-Chuan ;
Chao, Ta-Chung ;
Liu, Jin-Hwang ;
Chiou, Tzeon-Jye ;
Chen, Po-Min .
ANNALS OF HEMATOLOGY, 2007, 86 (02) :95-100
[8]
Fludarabine, mitoxantrone, and dexamethasone: An effective new regimen for indolent lymphoma [J].
McLaughlin, P ;
Hagemeister, FB ;
Romaguera, JE ;
Sarris, AH ;
Pate, O ;
Younes, A ;
Swan, F ;
Keating, M ;
Cabanillas, F .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) :1262-1268
[9]
SALVAGE THERAPY WITH CLINDAMYCIN PRIMAQUINE FOR PNEUMOCYSTIS-CARINII PNEUMONIA [J].
NOSKIN, GA ;
MURPHY, RL ;
BLACK, JR ;
PHAIR, JP .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (01) :183-188
[10]
Pneumocystis carinii pneumonia in patients with malignant haematological diseases:: 10 years' experience of infection in GIMEMA centres [J].
Pagano, L ;
Fianchi, L ;
Mele, L ;
Girmenia, C ;
Offidani, M ;
Ricci, P ;
Mitra, ME ;
Picardi, M ;
Caramatti, C ;
Piccaluga, P ;
Nosari, A ;
Buelli, M ;
Allione, B ;
Cortelezzi, A ;
Fabbiano, F ;
Milone, G ;
Invernizzi, R ;
Martino, B ;
Masini, L ;
Todeschini, G ;
Cappucci, MA ;
Russo, D ;
Corvatta, L ;
Martino, P ;
Del Favero, A .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (02) :379-386